A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -71.18% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -27.11%. Over the past 30 days, the price of RDHL has leaped by -20.54%. And in the last five days, it has fallen by -7.33%.
Redhill Biopharma Ltd. ADR ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $3.28 on 11/29/23, while the lowest value for the same period was recorded at $0.26 on 10/13/23.
52-week price history of RDHL Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Redhill Biopharma Ltd. ADR’s current trading price is -87.17% away from its 52-week high, while its distance from the 52-week low is 63.74%. The stock’s price range during this period has varied between$0.26 and $3.28. The Redhill Biopharma Ltd. ADR’s shares, which operate in the Healthcare, saw a trading volume of around 0.66 million for the day, a figure considerably lower than their average daily volume of 1.22 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Redhill Biopharma Ltd. ADR (RDHL) has experienced a quarterly decline of -57.47% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 12.50M and boasts a workforce of 53 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8640, with a change in price of +0.1098. Similarly, Redhill Biopharma Ltd. ADR recorded 6,357,414 in trading volume during the last 100 days, posting a change of +35.31%.
RDHL’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RDHL stands at 0.66. Similarly, the long-term debt-to-equity ratio is also 0.29.
RDHL Stock Stochastic Average
Redhill Biopharma Ltd. ADR’s raw stochastic average for the past 50 days is presently 34.59%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 45.77%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 36.79% and 23.58%, respectively.
